Clinical research organization India
clinical trials india Welcome

Your success. That’s our commitment at Excel Life Sciences. Everything we do is built around leveraging our expertise and passion to ensure that your clinical trials are successful. As the leading Trial Management Organization in India and through our trusted partnerships worldwide, we have the capabilities and bandwidth to take on any project large or small. And with offices and executive leadership based in the United States, you can be sure that we’re available when you are. Excel Life Sciences mixes a customized consultative approach with industry-leading experience and know-how to get results. Specifically our team’s experience includes:

  • 280 years combined experience in Clinical Medicine, Pharmaceutical Medicine and Biometrics
  • 50 years of regulatory experience and top USA and India regulatory executive’s on the ELS advisory board 
  • 350 successfully conducted clinical trials at over 1000 sites 
  • 135 IND approvals & 20+ NDA approvals in US, Europe & Asia
clinical trials india What's New at ELS

Excel Life Sciences Continues Successful Management of Clinical Trials in India as Regulators work to Improve Review Process

Excel Life Sciences President and Chief Medical Officer, Dr. Vijai Kumar, is featured in a just released story on the evolving clinical research landscape in India.  The article which appears in the web-based publication, eCliniqua, discusses some of the ongoing changes underway to create a more robust, efficient and predictable regulatory review process in India for clinical trials. Dr. Kumar shares information on the approach Excel Life Sciences takes to ensure timely regulatory approval for its clients global clinical trials. The company, with a unique operating model involving deployment of its own onsite clinical research coordinators to each site, prides itself on running ethical trials and delivering data quality and data integrity to its clients. Please click here to read the full article

 

Regeneron Pharmaceuticals, Inc. R&D Chief Reveals Allergy Drug May Be Darling Of Its Pipeline

Angelina Jolie Surgery Sparks Surge In Female Cancer Tests

Takeda Pharmaceutical Co. Ltd. Backs Weight Loss Drug Contrave With 900 Sales Reps

Can One Dose Of Antidepressant Lead To Changes In Your Brain? Study

People With Larger Pupil Size Are Bad Decision Makers, Study

Sedentary Lifestyle Linked To Depression, Study

Allozyne, Inc. Sold For Scrap As MedImmune Snaps Up Rights

New Branch Added To European Family Tree, Harvard Medical School Study

Vitamin E, Selenium Don't Seem To Prevent Cataracts, Brigham and Women's Hospital And Harvard Medical School Study

Yoga May Help People With Bipolar Disorder, Brown University Survey Reveals

PTSD Link To Food Addiction, University of Minnesota Study

Eli Lilly and Company Gets Thumbs Up From FDA For Diabetes Drug Trulicity

Chinese Court Hits GlaxoSmithKline With $492M Bribery Fine

Health Canada Requests Quarantine Of Ipca Laboratories' Products Following Falsification And Manipulation Of Data Issues

60 Percent Of New York???s Hep C Patients Will Get Gilead Sciences, Inc.'s Sovaldi

GlaxoSmithKline Will End Promotional Pay To Doctors

World Population To Keep Growing This Century, Hit 11 Billion By 2100, University of Washington Study

EU Approval Of Gilead Sciences, Inc.'s Zydelig Nothing But Good News, Says Analyst

FDA Panel Denies Clarus Therapeutics' Oral Testosterone Drug Rextoro

Horizon Pharma plc. Moves To Ireland As Frustrated Lawmakers Look On

Natco Pharma Limited, Hit With A Strong Dose Of FDA Medicine

Soligenix Awarded National Institute of Allergy And Infectious Diseases (NIAID) Contract Valued Up To $24.7 Million

AmpliPhi Biosciences Corporation Announces Departure Of CEO

Top 10 Fastest Growing Employers Outside Of Big Pharma

Novartis AG Discloses More Layoffs At New York Plant

Cubist Pharmaceuticals, Inc. Opens Global HQ; To Invest Approximately $400 Million On Antibiotic R&D

Auxilium Pharmaceuticals, VIVUS, Inc.'s Faster-Acting Erectile Dysfunction Drug Wins FDA Approval

Roche To Invest $535M, Create 3,500 Jobs At New Swiss IT Site

The Science Of How Diet Sodas Are Making You Fat , Weizmann Institute of Science Study

Gilead Sciences, Inc.'s Experimental Drug Simtuzumab Fails Mid-Stage Study

Bayer AG Will Spin Off Plastics To Focus On Life Sciences

Flexion Therapeutics Reports FDA Clinical Hold For Phase 2b Trial Of Osteoarthritis Drug

Nurix Names Chief Executive Officer

Merck KGaA Appoints New Deputy Chief As CEO Succession Is Pondered

Novo Nordisk A/S's Diabetes Drug Ryzodeg Effective In Phase 3b Study

Baxter International, Inc. Recalls One Lot Of Potassium Chloride Injection

Biotech Venture Capital Firm Launches New $65 Million Oncology Fund

AbbVie Sued By Louisiana Pension Fund Over $54.5 Billion Shire Pharmaceuticals Deal

GlaxoSmithKline Resolves Violation Issue At Montana Facility

ProQR Therapeutics B.V. Prices IPO At $13 A Share

Foamix Pharmaceuticals, Ltd. Prices IPO At $6 A Share

FDA Delays Decision On IMPAX Laboratories, Inc. Parkinson's Drug RYTARY

Merck KGaA Wants Bids For Cancer Therapy Partners

Novo Nordisk A/S May Add Hundreds To R&D Staff For Obesity Medicines

Boehringer Ingelheim Corporation Will Pay Up To $600 Million For CureVac GmbH Lung Cancer Vaccine

Pfizer And Merck & Co. Execs Exclusive: Inside Tips For Getting Hired

Agilent Technologies Inc. Announces CEO Transition: To Succeed In March 2015

Why Asian Americans Are At Higher Risk Of Developing Type 2 Diabetes, Joslin Diabetes Center Study

Size At Birth Signals Likelihood Of Mental Health Disorders, University of Copenhagen Study

Parkinson's Disease Myth Debunked, University of Copenhagen Study

Regeneron Pharmaceuticals, Inc. Wins Breakthrough Therapy Designation From FDA For EYLEA

Mid-Life Migraines Sufferers More Likely To Develop Parkinson's, Uniformed Services University Study

Being Around Smart Teens May Make College More Likely, Brigham Young University Study Shows

Do Clinical Trials In Canada Suffer From Poor Oversight?

Sharks' Skin May Fight Against Hospital Superbugs, /i> Reveals

How You Pick Romantic Partners Could Be A Matter Of Tiny Words, University of Texas Study

Human Faces Are Evolved To Look Unique, University of California, Berkeley (CAL) Study

Intestinal Bacteria May Boost Flu Shot's Effects, Emory University Study

Failing Students Saved By Stress-Detecting App, Dartmouth College Study

Aggressive People React Differently To Media Violence, Mount Sinai School of Medicine Study

What Gets Wrong About Big Pharma

For Roche CEO, Celebrating Failure Is Key To Success

Bay Area Startup MyoKardia Forges $200 Million Heart Disease Pact With Sanofi (France)

Asian Investor In Talks To Buy, Build Massive Burlingame Site; Will It Hold Biotech Or Tech Tenants?

Moving On From A Botched Novartis AG Deal, Proteon Therapeutics, Inc. Turns To Plan B: IPO

Allergan Inc. To Slash 129 California Jobs Amid Hostile Takeover Battle

Looming Patent Deadline Pushes Sanofi (France) To Be More Aggressive; Wants To Add Oral GLP-1 To Diabetes Offering

Analyst: Gilead Sciences, Inc. Still A Buy After Cancer Drug Fail

Auxilium Pharmaceuticals Institutes "Poison Pill" To Fend Off $2.2B Endo Pharmaceuticals Offer

Takeda Pharmaceutical Co. Ltd. To Headquarter Global Oncology Unit In Crowded Cambridge

Sun Pharmaceutical Industries Ltd Buys Rights To Tildrakizumab From Merck & Co. For An Upfront Payment Of $80 Million

South San Francisco's Sutro Biopharma Forges $375 Million Antibody Drug Pact With Merck KGaA

Swiss Biopharma Enters Euro 45 Million Financing Deal

Salix Pharmaceuticals, Ltd. Faces Shareholder Revolt On Cosmo Pharmaceuticals S.p.A. Deal

Johnson & Johnson's Biggest Plant Coming Up In Telangana

Eli Lilly and Company Bets $500 Million On AstraZeneca PLC???s Alzheimer's Drug

Tokai Pharmaceuticals Bags $97 Million For Prostate Cancer Drug In Upsized IPO

New York-Based SIGA Technologies, Inc. Files For Bankruptcy

American Waistlines Continues To Expand At Alarming Rate, Centers for Disease Control and Prevention (CDC) Reveals

Merck & Co.'s Long-Delayed Osteoporosis Drug Passes Trial

Schizophrenia Is Actually Eight Different Diseases, Washington University in St. Louis Study

Cardiorespiratory Fitness Slashes High Blood Pressure Hikes In Men, University of South Carolina Study

Certain Form Of Baldness Linked To Prostate Cancer, National Cancer Institute Study

Human Hair Discovered In Heparin Vial Prompts Hospira, Inc. Recalls

You're Attracted To The Body Odor Of Those With Similar Political Beliefs, /i> Reveals

High-Fat Dairy Cuts Type 2 Diabetes Risk, Study

India???s Dept Of Biotech Plans Financial Help For The Biotech Industry

Too Many Science PhDs? Not If Universities Train Them For Careers Outside Academia

FDA Approves AstraZeneca PLC, Nektar Therapeutics (CA)'s MOVANTIK™ For Opioid-Induced Constipation

Fall Parade Of Biotech IPOs Sees Heavy Lineup

Novartis AG, Roche Cry Foul On New Swiss Pricing System

Lupin Ltd., Merck Serono Forge Emerging Markets Pact; Deal Could Add Up To 20 Drugs To Portfolio

UC Launches $250M Venture Fund To Back Homegrown Startups

Google Inc.-Backed Calico Announces Plan To Combat ALS, Parkinson's

Wall Street Shouldn't Write Off Ampio Pharmaceuticals, Inc. Yet: Citi Analysts

Study Shows Novo Nordisk A/S's New Diabetes Drug Tresiba Effective And Safe For Children

Dimension Therapeutics Appoints New CEO,

GlaxoSmithKline Exercises Option For Five Prime Therapeutics, Inc.'s Skeletal Muscle Drugs

Cambridge, Mass.-Based Biotech Startup Reels In $20 Million

Israeli Biotech NeuroDerm Ltd. Files For $65 Million IPO

Analyst: Safety Worries Dog Merck & Co.???s Osteoporosis Drug

Experimental Northwest Biotherapeutics Drug Gets First Slot Under UK Early Access Scheme

Gilead Sciences, Inc. Says Indian Firms May Sell Generics of Hep C Drug Sovaldi

AVANIR Pharmaceuticals Rockets As Lead Drug Succeeds In Reducing Alzheimer's Related Agitation; Stock Up 63.20% At 10:19AM ET On Monday

High Protein Diets Lead To Lower Blood Pressure, Boston University Medical Center Study Finds

Human Language Gene Makes Mice Smarter, Massachusetts Institute of Technology (MIT) Study

Inflammation May Be Key To Diabetes/Heart Disease Link, Study

UNC Researchers Find Final Pieces To The Circadian Clock Puzzle

DIY Drugs: Antibiotics May Soon Be Made Out Of Our Own Bacteria, University of California, San Francisco (UCSF) Researchers Discover

Sleep Doesn't Stop The Brain: Words Are Still Being Classified, Study

Honesty Linked To The Prefrontal Region Of The Brain, University of California, Berkeley (CAL) Study

Retrophin, Inc., Gilead Sciences, Inc., And Our Healthcare Values

Ex-AVEO Oncology Executive Takes COO Job At Biotech Startup

Lupin Ltd. May Sign $1.5 Billion Deal With Merck Serono; Stock Hits A New High

Johnson & Johnson Slashes Pensions For New Hires As Cuts Continue

FDA Approves Baxter International, Inc., Halozyme Therapeutics, Inc.'s HYQVIA

Regeneron Pharmaceuticals, Inc. Executive Outlines Strategy For Avoiding Affordable Care Act Penalties

Celgene VP Now Contender In Best Hair In Biopharma Contest

Roche Starts Pivotal Late-Stage Trial For Eye Drug Lampalizumab

Molecular Templates Inc. Announces Completion Of $12 Million Series C Financing

California Biotech Firm PSC Biotech Will Hire 100 To Make Cancer Drugs In Wisconsin

Google Inc. Dives Deeper Into Biotech With Acquisition

FDA Panel Recommends Approval Of NPS Pharmaceuticals, Inc.'s Natpara To Treat Hypoparathyroidism

Roche Battles Counterfeit Rituxin Vials In Germany

Sunny Skies Linked To Suicide Rates, University of Vienna Study

222


    Read more..